Aprea Therapeutics Inc (APRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 89,018 | 101,147 | 112,862 | 122,513 | 130,089 |
| TOTAL | $92,417 | $102,404 | $114,337 | $124,604 | $133,045 |
| Non-Current Assets | |||||
| PPE Net | 39 | 41 | 44 | 46 | 42 |
| Other Non-Current Assets | 350 | 390 | 438 | 475 | 522 |
| TOTAL | $389 | $431 | $482 | $521 | $563 |
| Total Assets | $92,805 | $102,834 | $114,819 | $125,125 | $133,608 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,504 | 4,350 | 5,443 | 3,007 | 2,177 |
| Accrued Expenses | 10,571 | 9,084 | 8,828 | 8,299 | 6,643 |
| TOTAL | $15,331 | $13,679 | $14,513 | $11,544 | $9,062 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 79 | 133 | 186 | 227 | 303 |
| TOTAL | $79 | $133 | $186 | $227 | $303 |
| Total Liabilities | $15,410 | $13,812 | $14,698 | $11,772 | $9,364 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,059 | 1,059 | 1,059 | 1,053 | 1,053 |
| Common Shares | 21 | 21 | 21 | 21 | 21 |
| Retained earnings | -144,007 | -128,615 | -116,296 | -99,929 | -90,528 |
| Other shareholders' equity | -10,037 | -12,371 | -12,202 | -13,959 | -11,534 |
| TOTAL | $77,395 | $89,023 | $100,120 | $113,354 | $124,244 |
| Total Liabilities And Equity | $92,805 | $102,834 | $114,819 | $125,125 | $133,608 |